Evidence map›Paper›PMID 27656398›Full record

ArticleMolecular metabolism2016

An ancestral role for the mitochondrial pyruvate carrier in glucose-stimulated insulin secretion.

Kyle S McCommis, Wesley T Hodges, Daniel K Bricker, Dona R Wisidagama, Vincent Compan, Maria S Remedi, Carl S Thummel, Brian N Finck

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Transgenic Cotton Expressing dsInternational journal of molecular sciences · 2024
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. The mitochondrial pyruvate carrier at the crossroads of intermediary metabolism.American journal of physiology. Endocrinology and metabolism · 2022
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Kyle S McCommisDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Wesley T HodgesDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Daniel K BrickerDepartment of Human Genetics, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
Dona R WisidagamaDepartment of Human Genetics, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
Vincent CompanInstitute of Functional Genomics, Labex ICST; INSERM U1191, CNRS UMR5203; University of Montpellier, Montpellier, France.
Maria S RemediDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Carl S ThummelDepartment of Human Genetics, University of Utah School of Medicine, Salt Lake City, UT 84112, USA. Electronic address: carl.thummel@genetics.utah.edu.
Brian N FinckDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address: bfinck@dom.wustl.edu.
Washington University in St. Louis · USUniversity of Utah · USUniversité de Montpellier · FR

Funding

Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 1999 to 2026
$30.2M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Clay F. Semenkovich · 2013 to 2026
$27.1M
DIABETES &RELATED METABOLIC DISEASEST32DK007120 · NIDDK · WASHINGTON UNIVERSITY · PI MARCO COLONNA, Maria Sara Remedi · 1986 to 2026
$15.7M
TARGETING THE MITOCHONDRIAL PYRUVATE CARRIER TO TREAT NONALCOHOLIC STEATOHEPATITISR01DK104735 · NIDDK · WASHINGTON UNIVERSITY · PI FINCK, BRIAN N · 2015 to 2025
$7.1M
TRAINING PROGRAM IN GENETICST32GM007464 · NIGMS · UNIVERSITY OF UTAH · PI GRUNWALD, DAVID J., STANFIELD, GILLIAN · 1985 to 2020
$6.1M
CELL BIOLOGIC APPROACHES TO DIABETES RESEARCHT32DK007296 · NIDDK · WASHINGTON UNIVERSITY · PI COLONNA, MARCO · 1986 to 2014
$3.3M
Novel insulin-sensitizing NASH/diabetes drugs.R42DK121652 · NIDDK · BIOIO, LLC · PI FINCK, BRIAN N, PETERSON, TIMOTHY R · 2019 to 2022
$1.7M
BETA-CELL EXHAUSTION AND GLUCOTOXICITY IN DIABETESR01DK098584 · NIDDK · WASHINGTON UNIVERSITY · PI REMEDI, MARIA SARA · 2013 to 2017
$1.7M
Evaluation of PPARgam-sparing TZDs for Treating Non-Alcoholic Fatty Liver DiseaseR42AA021228 · NIAAA · METABOLIC SOLUTIONS DEVELOPMENT CO · PI FINCK, BRIAN N, KLETZIEN, ROLF F · 2011 to 2012
$1.2M
Functions of the Mitochondrial Proteome: An Integrated Multi-Species ApproachR01GM094232 · NIGMS · UNIVERSITY OF UTAH · PI RUTTER, JARED P, THUMMEL, CARL S. · 2012 to 2015
$1.2M
NIAAA NIH HHS R42 AA021228NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK056341NIDDK NIH HHS R01 DK098584NIDDK NIH HHS R01 DK104735NIDDK NIH HHS R42 DK121652NIDDK NIH HHS T32 DK007120NIDDK NIH HHS T32 DK007296NIGMS NIH HHS R01 GM094232NIGMS NIH HHS T32 GM007464
6 · The paper itself

Abstract

objectiveTransport of pyruvate into the mitochondrial matrix by the Mitochondrial Pyruvate Carrier (MPC) is an important and rate-limiting step in its metabolism. In pancreatic β-cells, mitochondrial pyruvate metabolism is thought to be important for glucose sensing and glucose-stimulated insulin secretion.

methodsTo evaluate the role that the MPC plays in maintaining systemic glucose homeostasis, we used genetically-engineered Drosophila and mice with loss of MPC activity in insulin-producing cells.

resultsIn both species, MPC deficiency results in elevated blood sugar concentrations and glucose intolerance accompanied by impaired glucose-stimulated insulin secretion. In mouse islets, β-cell MPC-deficiency resulted in decreased respiration with glucose, ATP-sensitive potassium (KATP) channel hyperactivity, and impaired insulin release. Moreover, treatment of pancreas-specific MPC knockout mice with glibenclamide, a sulfonylurea KATP channel inhibitor, improved defects in islet insulin secretion and abnormalities in glucose homeostasis in vivo. Finally, using a recently-developed biosensor for MPC activity, we show that the MPC is rapidly stimulated by glucose treatment in INS-1 insulinoma cells suggesting that glucose sensing is coupled to mitochondrial pyruvate carrier activity.

conclusionsAltogether, these studies suggest that the MPC plays an important and ancestral role in insulin-secreting cells in mediating glucose sensing, regulating insulin secretion, and controlling systemic glycemia.

Indexed as

DiabetesDILP2, Drosophila insulin-like peptide 2DrosophilaGSIS, glucose-stimulated insulin secretionGTT, glucose tolerance testIMM, inner mitochondrial membraneInsulinIPCs, Insulin-producing CellsITT, insulin tolerance testMitochondriaMPC1 and MPC2, Mitochondrial Pyruvate Carrier 1 and 2OCR, oxygen consumption ratesPdx1, pancreatic and duodenal homeobox 1PyruvateRESPYR, REporter Sensitive to PYRuvateStimulus-coupled secretionβ-Cell

Identifiers

PMID27656398
PMCPMC5021712
OpenAlexW2467705229

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.